Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).
暂无分享，去创建一个
M. Dimopoulos | U. Dafni | A. Psyrri | G. Fountzilas | A. Bamias | C. Deliveliotis | D. Pectasides | A. Bamias | V. Koutoulidis | A. Eleftheraki | I. Xanthakis | E. Timotheadou | E. Samantas | A. Karadimou | G. Aravantinos | M. Tsiatas | K. Stravodimos | A. Visvikis | C. Deliveliotis | C. Constantinidis | C. Hatzimouratidis | M. Chrisophos | Meletios-Athanassios Dimopoulos